• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白激酶Cδ通过抑制血管舒张刺激蛋白(VASP)介导的丝状伪足形成来调节胶原蛋白诱导的血小板聚集。

PKCdelta regulates collagen-induced platelet aggregation through inhibition of VASP-mediated filopodia formation.

作者信息

Pula Giordano, Schuh Kai, Nakayama Keiko, Nakayama Keiichi I, Walter Ulrich, Poole Alastair W

机构信息

Department of Pharmacology, School of Medical Sciences, University of Bristol, United Kingdom.

出版信息

Blood. 2006 Dec 15;108(13):4035-44. doi: 10.1182/blood-2006-05-023739. Epub 2006 Aug 29.

DOI:10.1182/blood-2006-05-023739
PMID:16940418
Abstract

Protein kinase Cdelta (PKCdelta) has been shown by pharmacologic approaches to negatively regulate collagen-induced platelet aggregation. Here we addressed the molecular and cellular mechanisms underlying this negative regulation. Using PKCdelta-/- platelets, we show that the mechanism did not involve altered inside-out signaling to integrin alpha(IIb)beta3 and did not affect early signaling events downstream of GPVI, because there was no difference in tyrosine phosphorylation of PLCgamma2 between wild-type and PKCdelta-/- platelets. There was also no increase in secretion of dense granule content, in contrast to studies using rottlerin where secretion was enhanced. Importantly, however, there was marked enhancement of filopodia generation in PKCdelta-/- platelets upon adhesion to collagen compared with wild-type platelets. Filopodia play an essential role regulating adhesive events leading to platelet aggregation by increasing platelet-platelet contact. We show that the critical effector for PKCdelta is vasodilator-stimulated phosphoprotein (VASP), a major regulator of actin cytoskeleton dynamics. PKCdelta physically interacts with VASP constitutively and regulates its phosphorylation on Ser157. In VASP-/- platelets, the enhancement of filopodia generation, actin polymerization, and platelet aggregation by rottlerin is ablated. PKCdelta is therefore a critical negative regulator of filopodia, and hence platelet aggregation, through a functional interaction with the actin organizer VASP.

摘要

药理学方法已表明蛋白激酶Cδ(PKCδ)对胶原诱导的血小板聚集具有负调控作用。在此,我们探讨了这种负调控背后的分子和细胞机制。使用PKCδ基因敲除小鼠的血小板,我们发现该机制不涉及整合素α(IIb)β3外向内信号转导的改变,也不影响GPVI下游的早期信号事件,因为野生型和PKCδ基因敲除小鼠的血小板中PLCγ2的酪氨酸磷酸化没有差异。与使用rottlerin(分泌增强)的研究不同,致密颗粒内容物的分泌也没有增加。然而,重要的是,与野生型血小板相比,PKCδ基因敲除小鼠的血小板在黏附于胶原时丝状伪足生成显著增强。丝状伪足通过增加血小板-血小板接触在调节导致血小板聚集的黏附事件中起重要作用。我们发现PKCδ的关键效应分子是血管舒张刺激磷蛋白(VASP),它是肌动蛋白细胞骨架动力学的主要调节因子。PKCδ与VASP持续发生物理相互作用并调节其Ser157位点的磷酸化。在VASP基因敲除小鼠的血小板中,rottlerin对丝状伪足生成、肌动蛋白聚合和血小板聚集的增强作用被消除。因此,PKCδ通过与肌动蛋白组织者VASP的功能相互作用,是丝状伪足以及血小板聚集的关键负调控因子。

相似文献

1
PKCdelta regulates collagen-induced platelet aggregation through inhibition of VASP-mediated filopodia formation.蛋白激酶Cδ通过抑制血管舒张刺激蛋白(VASP)介导的丝状伪足形成来调节胶原蛋白诱导的血小板聚集。
Blood. 2006 Dec 15;108(13):4035-44. doi: 10.1182/blood-2006-05-023739. Epub 2006 Aug 29.
2
Ginsenoside-Rp3 inhibits platelet activation and thrombus formation by regulating MAPK and cyclic nucleotide signaling.人参皂苷-Rp3 通过调节 MAPK 和环核苷酸信号通路抑制血小板活化和血栓形成。
Vascul Pharmacol. 2018 Oct;109:45-55. doi: 10.1016/j.vph.2018.06.002. Epub 2018 Jun 8.
3
The Ca(2+) /calmodulin-dependent kinase kinase β-AMP-activated protein kinase-α1 pathway regulates phosphorylation of cytoskeletal targets in thrombin-stimulated human platelets.钙(Ca2+)/钙调蛋白依赖性激酶激酶 β-AMP 激活的蛋白激酶-α1 通路调节凝血酶刺激的人血小板中细胞骨架靶标的磷酸化。
J Thromb Haemost. 2014 Jun;12(6):973-86. doi: 10.1111/jth.12568.
4
Vasodilator-Stimulated Phosphoprotein (VASP)-dependent and -independent pathways regulate thrombin-induced activation of Rap1b in platelets.血管舒张刺激磷蛋白(VASP)依赖性和非依赖性途径调节凝血酶诱导的血小板中Rap1b的激活。
Cell Commun Signal. 2016 Sep 13;14(1):21. doi: 10.1186/s12964-016-0144-z.
5
CGX1037 is a novel PKC isoform delta selective inhibitor in platelets.CGX1037是一种新型的血小板中蛋白激酶Cδ同工型选择性抑制剂。
Platelets. 2015;26(1):2-9. doi: 10.3109/09537104.2013.868877. Epub 2014 Jan 16.
6
VASP protects actin filaments from gelsolin: an in vitro study with implications for platelet actin reorganizations.血管扩张刺激磷蛋白保护肌动蛋白丝免受凝溶胶蛋白的影响:一项对血小板肌动蛋白重组有启示意义的体外研究。
Cell Motil Cytoskeleton. 2000 Dec;47(4):351-64. doi: 10.1002/1097-0169(200012)47:4<351::AID-CM8>3.0.CO;2-8.
7
VASP phosphorylation at serine239 regulates the effects of NO on smooth muscle cell invasion and contraction of collagen.丝氨酸239位点的血管扩张刺激磷蛋白(VASP)磷酸化调节一氧化氮(NO)对平滑肌细胞侵袭和胶原蛋白收缩的影响。
J Cell Physiol. 2010 Jan;222(1):230-7. doi: 10.1002/jcp.21942.
8
Phosphorylation of focal adhesion vasodilator-stimulated phosphoprotein at Ser157 in intact human platelets correlates with fibrinogen receptor inhibition.在完整的人血小板中,粘着斑血管舒张刺激磷蛋白在丝氨酸157位点的磷酸化与纤维蛋白原受体抑制相关。
Eur J Biochem. 1994 Oct 1;225(1):21-7. doi: 10.1111/j.1432-1033.1994.00021.x.
9
Ginsenoside-Rp1 inhibits platelet activation and thrombus formation via impaired glycoprotein VI signalling pathway, tyrosine phosphorylation and MAPK activation.人参皂苷-Rp1 通过抑制糖蛋白 VI 信号通路、酪氨酸磷酸化和 MAPK 激活来抑制血小板活化和血栓形成。
Br J Pharmacol. 2012 Sep;167(1):109-27. doi: 10.1111/j.1476-5381.2012.01967.x.
10
A noble function of BAY 11-7082: Inhibition of platelet aggregation mediated by an elevated cAMP-induced VASP, and decreased ERK2/JNK1 phosphorylations.BAY 11-7082 的一个重要功能:通过升高的 cAMP 诱导的 VASP 和降低的 ERK2/JNK1 磷酸化来抑制血小板聚集。
Eur J Pharmacol. 2010 Feb 10;627(1-3):85-91. doi: 10.1016/j.ejphar.2009.11.005. Epub 2009 Nov 10.

引用本文的文献

1
Pharmacological inhibition of Septins with Forchlorfenuron attenuates thrombus formation in experimental thrombotic mice models with modulating multiple signaling pathways in platelets.用氯吡脲对Septin进行药理学抑制可减轻实验性血栓形成小鼠模型中的血栓形成,同时调节血小板中的多种信号通路。
J Adv Res. 2025 Jul;73:517-533. doi: 10.1016/j.jare.2024.08.006. Epub 2024 Aug 5.
2
In vitro Hemostatic Functions of Cold-Stored Platelets.冷储存血小板的体外止血功能
Transfus Med Hemother. 2023 Nov 16;51(2):94-100. doi: 10.1159/000533735. eCollection 2024 Apr.
3
Essential role of CD38 in platelet aggregation through the PKC-mediated internalization and activation.
CD38通过蛋白激酶C介导的内化和激活在血小板聚集中的重要作用。
Bioimpacts. 2024;14(2):27780. doi: 10.34172/bi.2023.27780. Epub 2023 Sep 30.
4
Platelet C3G: a key player in vesicle exocytosis, spreading and clot retraction.血小板 C3G:囊泡胞吐、扩散和血栓回缩的关键参与者。
Cell Mol Life Sci. 2024 Feb 12;81(1):84. doi: 10.1007/s00018-023-05109-8.
5
derived lipophosphoglycan influences the host's early immune response by inducing platelet activation and DKK1 production via TLR1/2.衍生的脂磷寡糖通过 TLR1/2 诱导血小板活化和 DKK1 产生来影响宿主的早期免疫反应。
Front Immunol. 2023 Oct 11;14:1257046. doi: 10.3389/fimmu.2023.1257046. eCollection 2023.
6
The mechanism of oleic acid inhibiting platelet activation stimulated by collagen.油酸抑制胶原蛋白刺激的血小板活化的机制。
Cell Commun Signal. 2023 Oct 10;21(1):278. doi: 10.1186/s12964-023-01276-0.
7
Filopodial adhesive force in discrete nodes revealed by integrin molecular tension imaging.离散节点中丝状伪足黏附力的整合素分子张力成像显示。
Curr Biol. 2022 Oct 24;32(20):4386-4396.e3. doi: 10.1016/j.cub.2022.08.040. Epub 2022 Sep 8.
8
An Insight into Recent Advances on Platelet Function in Health and Disease.浅析健康与疾病中血小板功能的最新进展。
Int J Mol Sci. 2022 May 27;23(11):6022. doi: 10.3390/ijms23116022.
9
Dimethylamine enhances platelet hyperactivity in chronic kidney disease model.二甲胺增强慢性肾病模型中的血小板高反应性。
J Bioenerg Biomembr. 2021 Oct;53(5):585-595. doi: 10.1007/s10863-021-09913-4. Epub 2021 Jul 30.
10
mTOR regulates GPVI-mediated platelet activation.mTOR 调控 GPVI 介导的血小板活化。
J Transl Med. 2021 May 10;19(1):201. doi: 10.1186/s12967-021-02756-y.